An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma

G.P. Kim, M.R. Mahoney, D. Szydlo, T.S.K. Mok, R. Marshke, K. Holen, J. Picus, M. Boyer, H.C. Pitot, J. Rubin, P.A. Philip, Anna Nowak, J.J. Wright, C. Erlichman

Research output: Contribution to journalArticle

42 Citations (Scopus)
Original languageEnglish
Pages (from-to)387-394
JournalInvestigational New Drugs
Volume30
DOIs
Publication statusPublished - 2012

Cite this

Kim, G. P., Mahoney, M. R., Szydlo, D., Mok, T. S. K., Marshke, R., Holen, K., ... Erlichman, C. (2012). An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Investigational New Drugs, 30, 387-394. https://doi.org/10.1007/s10637-010-9532-1